Researchers have conducted an extensive evaluation of models predicting haemorrhagic transformation (HT) following ischaemic strokes, aiming to enhance patient risk stratification and improve clinical outcomes. The comprehensive review analyzed both traditional statistical approaches and advanced machine learning techniques to determine their effectiveness in foreseeing this serious complication.
Scope and Methodology of the Review
The team meticulously searched databases including PubMed and Ovid-Embase, identifying 100 relevant studies. These comprised 67 studies focused on developing prediction models and 33 dedicated to validating existing ones. Traditional models predominantly utilized the National Institutes of Health Stroke Scale (NIHSS) as a key predictor, while machine learning models frequently employed support vector machines (SVM) as their algorithm of choice.
Findings and Model Performance
Among the validated models, eight demonstrated a pooled area under the receiver operating characteristic curve of approximately 0.70, indicating moderate predictive ability. However, the assessment revealed significant variability in the methodological quality of the studies, with only 26 out of 100 studies exhibiting a low risk of bias. Many models require further refinement to achieve higher accuracy and reliability in diverse clinical settings.
Inference:
- NIHSS scores remain a critical component in traditional HT prediction models.
- Support vector machines are the preferred algorithm in machine learning approaches for HT prediction.
- Current models exhibit moderate accuracy, limiting their standalone clinical utility.
- High variability in study quality underscores the need for standardized validation protocols.
The findings highlight that despite advancements in predictive modeling, both traditional and machine learning-based approaches face challenges related to methodological rigor and clinical applicability. The average predictive performance suggests these models can provide supplementary insights but should not replace clinical judgment.
Future directions emphasize the necessity for more robust validation processes, adherence to standardized reporting frameworks, and the integration of clinically meaningful predictors. Collaborative efforts across research institutions are essential to enhance the generalizability and reliability of HT prediction models, ultimately contributing to better patient management and outcomes.
Ongoing improvements in model development could lead to more precise and actionable tools for clinicians, facilitating timely interventions and personalized treatment plans for stroke patients at higher risk of haemorrhagic complications. The medical community stands to benefit significantly from continued research and innovation in this critical area of stroke care.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
